Lifevantage Corp (LFVN) Stock Price, Quote & News

Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre- and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplemen...

Industry: Packaged Foods

Sector: Consumer Defensive

Phone: 801 432 9000

Website: www.lifevantage.com

Address:

3300 North Triumph Boulevard, Suite 700, Lehi, United States

highnihilism Oct. 1 at 12:28 PM

0 · Reply

Pitoentuboca Sep. 25 at 7:15 PM

0 · Reply

Pitoentuboca Sep. 25 at 6:51 PM

$LFVN

0 · Reply

Pitoentuboca Sep. 25 at 6:22 PM

$LFVN IM ALL IN HERE $$$$$ I TRILLSION SHARES $$$$$ SMOEK BREAKE $$$$$$$$ I'LL COME BACK WHEN ITS $11

0 · Reply

highnihilism Sep. 16 at 7:34 PM

IWM: Russell 2000 → $LFVN Lifevantage $ARAY Accuray $MITT Ag Mortgage It $DIOD Diodes $MCY Mercury General

0 · Reply

highnihilism Sep. 16 at 7:32 PM

IWM: Russell 2000 → $KALU Kaiser Aluminum $NNOX Nano X Imaging $PRLB Proto Labs $LFVN Lifevantage $ARAY Accuray

0 · Reply

TimRegan_WTR Sep. 12 at 7:25 PM

$LFVN

0 · Reply

research_WTR Sep. 12 at 7:01 PM

LifeVantage Corporation (NASDAQ: LFVN) reported 4QFY25 EPS of $0.17, up 21.4% Y/Y and in line with expectations, as sales grew 12.6% to $55.1M. 🔹 FY26 guidance below expectations: Sales $225–240M, EBITDA $23–26M 🔹 Active accounts +3.1% Y/Y; Americas +6.4% led by consultant growth 🔹 Acquisition of LoveBiome expands into growing gut health market (CAGR 8.4%) 🔹 FY27 forecasts see sales & EBITDA growth with margin improvement LifeVantage continues to diversify into wellness & gut health while managing near-term sales volatility. Follow along with Douglas M. Lane, CFA at the link below! https://www.watertowerresearch.com/doc?docID=UR_LFVN_09092025 #LifeVantage $LFVN #Earnings #Wellness #GutHealth #SmallCap #Stocks #Investing

0 · Reply

justpassingthrough_ Sep. 5 at 4:54 PM

$LFVN mixed ER. Best way for this to reclaim ground is if the next ER shows international numbers for first full quarter of mind body that mirrored the first full quarter of US launch. Guess we’ll see. They could also just buy back shares to prop the SP, which they did do in the 12 range last quarter.

0 · Reply

d_risk Sep. 5 at 1:31 AM

$LFVN - Lifevantage Corporation Common Stock (Delaware) - 10K - Updated Risk Factors LFVN’s 10-K risk factors highlight expanded Evolve Compensation Plan rollout, increased reliance on Protandim, LifeVantage, and TrueScience lines, new acquisition and integration risks, international market exits, inventory tied to new product launches, patent expiration on Protandim Nrf2 Synergizer, and heightened exposure to tariffs, trade policy shifts, and health epidemics. #MultiLevelMarketing #TradePolicyRisk #PatentExpiration #ProductLaunchRisk #HealthSupplements 🟢 Added 🟠 Removed https://d-risk.ai/LFVN/10-K/2025-09-04

0 · Reply

LifeVantage Announces Closing of LoveBiome Acquisition

Sep 22, 2025, 8:00 AM EDT - 12 days ago

LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Sep 7, 2025, 11:24 PM EDT - 27 days ago

LifeVantage: Downgrading On Disappointing Results And Outlook - Hold

Sep 4, 2025, 7:37 PM EDT - 4 weeks ago

LifeVantage Corporation (LFVN) Q4 2025 Earnings Call Transcript

Sep 4, 2025, 4:05 PM EDT - 4 weeks ago

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025

Sep 3, 2025, 5:00 PM EDT - 4 weeks ago

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness

Sep 2, 2025, 4:05 PM EDT - 4 weeks ago

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 28, 2025, 4:05 PM EDT - 5 weeks ago

LifeVantage Declares Quarterly Dividend

Aug 21, 2025, 4:05 PM EDT - 6 weeks ago

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Results on September 4, 2025

Jul 24, 2025, 8:00 AM EDT - 2 months ago

LifeVantage To Open Iceland Market

Jul 22, 2025, 8:00 AM EDT - 2 months ago

LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡

Jul 21, 2025, 5:48 AM EDT - 2 months ago

The LifeVantage Advantage: High Retention, High Returns

Jul 15, 2025, 8:00 AM EDT - 2 months ago

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth

May 6, 2025, 9:09 PM EDT - 5 months ago

LifeVantage Corporation (LFVN) Q3 2025 Earnings Call Transcript

May 6, 2025, 4:05 PM EDT - 5 months ago

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025

May 5, 2025, 7:15 AM EDT - 5 months ago

LifeVantage: Activation Of Shareholder Value

Apr 28, 2025, 8:00 AM EDT - 5 months ago

Global Convention 2025 Empowers Consultants to ‘Go Further' with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth

Apr 22, 2025, 4:05 PM EDT - 5 months ago

LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025

Mar 17, 2025, 8:00 AM EDT - 7 months ago

LifeVantage Expands Global Reach with International Launch of the MB System™

Mar 3, 2025, 4:05 PM EST - 7 months ago

LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets

Feb 6, 2025, 12:06 PM EST - 8 months ago

LifeVantage: Post-Earnings Selloff Provides Buying Opportunity

Feb 5, 2025, 8:38 PM EST - 8 months ago

LifeVantage Corporation (LFVN) Q2 2025 Earnings Call Transcript

Jan 22, 2025, 4:05 PM EST - 9 months ago

LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025

Jan 16, 2025, 8:00 AM EST - 9 months ago

LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer

Jan 13, 2025, 8:05 AM EST - 9 months ago

LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™

Jan 11, 2025, 9:00 AM EST - 9 months ago

Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech +

CIVI ZENA

Jan 9, 2025, 8:36 AM EST - 9 months ago

LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major Winner - Buy

Jan 6, 2025, 4:05 PM EST - 9 months ago

LifeVantage to Participate in the 27th Annual ICR Conference

Jan 6, 2025, 7:49 AM EST - 9 months ago

Top 2 Defensive Stocks That May Crash In Q1

ODC

Dec 20, 2024, 8:54 AM EST - 10 months ago

Top 3 Risk Off Stocks That May Collapse This Month

NAPA PAVS

Oct 29, 2024, 9:49 PM EDT - 1 year ago

LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript

Oct 29, 2024, 4:07 PM EDT - 1 year ago

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025

Oct 15, 2024, 4:05 PM EDT - 1 year ago

LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024

Oct 14, 2024, 8:00 AM EDT - 1 year ago

LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle

Oct 1, 2024, 4:05 PM EDT - 1 year ago

LifeVantage Announces Update to Evolve Compensation Plan with New Sharing Bonus

Sep 4, 2024, 4:05 PM EDT - 1 year ago

LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 9:00 PM EDT - 1 year ago

LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript

Aug 28, 2024, 4:05 PM EDT - 1 year ago

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2024

Aug 26, 2024, 4:05 PM EDT - 1 year ago

LifeVantage Welcomes Rajendran Anbalagan to the Board of Directors; Thanks Erin Brockovich for Her Years of Service

Aug 26, 2024, 8:00 AM EDT - 1 year ago

LifeVantage Concludes Rise Retreat in Park City with Exclusive Preview of New Innovative Weight Management Solution

Aug 14, 2024, 4:05 PM EDT - 1 year ago

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2024 Results on August 28, 2024

Aug 5, 2024, 8:00 AM EDT - 1 year ago

LifeVantage Optimizes Rewards Circle with New Benefits for Both Consultants and Customers

Jul 22, 2024, 6:27 PM EDT - 1 year ago

LifeVantage To Host “LifeVantage Open House” Virtual Calls on July 23 and 24

Jul 22, 2024, 4:05 PM EDT - 1 year ago

LifeVantage Hosts Global Activate 2024 Event Teasing Major Product Launch

May 23, 2024, 8:00 AM EDT - 1 year ago

LifeVantage To Participate in Upcoming Investor Conferences

May 3, 2024, 10:44 AM EDT - 1 year ago

LifeVantage Corporation (LFVN) Q3 2024 Earnings Call Transcript

Apr 18, 2024, 4:05 PM EDT - 1 year ago

LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024

Mar 18, 2024, 8:00 AM EDT - 1 year ago

LifeVantage Wraps Up Momentum Academy 2024 with a Focus on Entrepreneurship and Growth

Mar 4, 2024, 8:00 AM EST - 1 year ago

LifeVantage Transforms the Future of Skin Health and Radiance: Introducing the TrueScience® Activated Skin Care Collection

Feb 16, 2024, 8:00 AM EST - 1 year ago

LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference

highnihilism Oct. 1 at 12:28 PM

0 · Reply

Pitoentuboca Sep. 25 at 7:15 PM

0 · Reply

Pitoentuboca Sep. 25 at 6:51 PM

$LFVN

0 · Reply

Pitoentuboca Sep. 25 at 6:22 PM

$LFVN IM ALL IN HERE $$$$$ I TRILLSION SHARES $$$$$ SMOEK BREAKE $$$$$$$$ I'LL COME BACK WHEN ITS $11

0 · Reply

highnihilism Sep. 16 at 7:34 PM

IWM: Russell 2000 → $LFVN Lifevantage $ARAY Accuray $MITT Ag Mortgage It $DIOD Diodes $MCY Mercury General

0 · Reply

highnihilism Sep. 16 at 7:32 PM

IWM: Russell 2000 → $KALU Kaiser Aluminum $NNOX Nano X Imaging $PRLB Proto Labs $LFVN Lifevantage $ARAY Accuray

0 · Reply

TimRegan_WTR Sep. 12 at 7:25 PM

$LFVN

0 · Reply

research_WTR Sep. 12 at 7:01 PM

0 · Reply

justpassingthrough_ Sep. 5 at 4:54 PM

0 · Reply

d_risk Sep. 5 at 1:31 AM

0 · Reply

Messerschmittbf109 Sep. 4 at 9:35 PM

$LFVN 10,5 -10,6 wait

0 · Reply

Hideo_Kuze Sep. 4 at 9:06 PM

Key positives from $LFVN filing (Q4 & FY2025): - Revenue growth: +14.2% YoY to $228.5M - Earnings surge: Diluted EPS up 3× (from $0.23 → $0.75) - Profitability: Adjusted EBITDA +30% to $22.1M - Strong balance sheet: $20.2M cash, zero debt - Shareholder returns: $3.1M buybacks + $0.045/share dividend declared - Margin expansion: Gross margin improved to 80.4%. - FY2026 guidance: Higher EPS ($1.00–$1.15) and EBITDA growth outlook ➡️ Net takeaway: Solid growth, stronger profits, clean balance sheet, and shareholder-friendly actions

3 · Reply

lozzamozza Sep. 4 at 9:06 PM

$LFVN 0 debt

0 · Reply

CatCapital_ai Sep. 4 at 8:08 PM

$LFVN Earnings - Q4/2025 Revenue: $55.1M ❌ vs. $56.89M est. EPS: $0.17 ❌ vs. $0.18 est. LifeVantage's fiscal 2025 capped with 13% quarterly revenue growth, returning to international sales — now up 8% after nearly three years. They’re guiding for FY2026 revenue of $225–$240M, with EBITDA of $23–$26M and EPS of $1.00–$1.15.

0 · Reply

justpassingthrough_ Sep. 3 at 9:33 PM

$LFVN unexpected news but we will know more on the call tomorrow. Hopefully allows them to issue aggressive guidance.

0 · Reply

6monthinvester Aug. 27 at 5:05 AM

$LFVN because of positive profitavikty reversal

0 · Reply

SilentSeer Aug. 25 at 5:56 PM

$LFVN at a key level (H4 timeframe) Current price: 13.27$ ✅ Key support: 12.73$ (Fib 0.236) ✅ Resistance just tested: 13.18$ 🎯 Potential targets (if 13.18$ breakout holds): First target: 13.53$ (Fib 0.5) Second target: 13.89$ (Fib 0.618) Optional target: 14.40$ (Fib 0.786) 🔥 Momentum is turning bullish, but confirmation requires a sustained close above 13.18$ with strong volume. Conclusion: As long as price holds above 12.73$, the bullish outlook remains valid. Worth watching closely… 👀

0 · Reply

BioTechHealthX Aug. 24 at 7:51 AM

$LFVN LifeVantage expanded fast with its wellness products, but investors are asking whether its MLM structure is sustainable. https://biotechhealthx.com/biotech-news/lifevantage-lfvn-faces-big-questions-despite-its-global-growth/

0 · Reply

justpassingthrough_ Aug. 23 at 8:54 PM

$LFVN big questions are (1) how is international launch going for revenue and (2) have they continued to improve ebitda margins. Hoping their launch is similar to us in terms of growth and that margins continue to increment up.

0 · Reply

SilentSeer Aug. 20 at 7:51 PM

$LFVN LFVN is currently trading at $12.42. A move back above $13.7 is needed to confirm real accumulation, while a breakout over $14.1 would strengthen the bullish case toward $17–18. Watching closely. #ConsumerStaples #PackagedFoods #LFVN #Trading #TechnicalAnalysis #Breakout

0 · Reply

Pitoentuboca Aug. 19 at 6:23 PM

$LFVN SOMEONE KNOWS SOMETHING CALLS BEING BOUGTH $$$$ ALMOST TIME TO BUY 13.20

0 · Reply

justpassingthrough_ Aug. 12 at 5:28 PM

$LFVN Could it be that the cheapie sellers are finally running out?

0 · Reply

Market Cap	120.31M
Revenue (ttm)	228.53M
Net Income (ttm)	9.81M
EPS (ttm)	N/A
PE Ratio	11.96
Forward PE	9.11
Profit Margin	4.29%
Debt to Equity Ratio	0.00

Volume	86,000
Avg Vol	137,696
Day's Range	N/A - N/A
Shares Out	12.69M
Stochastic %K	3%
Beta	0.26
Analysts	Sell
Price Target	$35.00